Caris Healthcare

Caris Life Sciences is a leading precision medicine and biotechnology company that provides comprehensive molecular profiling services to guide cancer treatment. The company's proprietary platform, the ADAPT Biotargeting System, utilizes a vast library of synthetic single-stranded DNA aptamers to identify novel biomarkers and drug targets. Beyond its diagnostic business, Caris has expanded into therapeutic development through its Caris Therapeutics division, focusing on the discovery and design of novel antibody-drug conjugates (ADCs) and other precision therapies. By integrating advanced AI and machine learning with one of the world's largest clinical-genomic datasets, Caris aims to accelerate drug discovery and improve patient outcomes in oncology. The company is headquartered in Irving, Texas, and maintains extensive partnerships with biopharmaceutical companies and academic research institutions.